Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trial.

MLA

Polosa, Riccardo, et al. “Weekly Low-Dose Methotrexate for Reduction of Global Initiative for Asthma Step 5 Treatment in Severe Refractory Asthma: Study Protocol for a Randomized Controlled Trial.” Trials, vol. 15, no. 1, Dec. 2014, pp. 295–310. EBSCOhost, https://doi.org/10.1186/1745-6215-15-492.

APA

Polosa, R., Bellinvia, S., Caruso, M., Emma, R., Alamo, A., Leszek Kowalski, M., & Domingo Ribas, C. (2014). Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trial. Trials, 15(1), 295–310. https://doi.org/10.1186/1745-6215-15-492

Chicago

Polosa, Riccardo, Salvatore Bellinvia, Massimo Caruso, Rosalia Emma, Angela Alamo, Marek Leszek Kowalski, and Christian Domingo Ribas. 2014. “Weekly Low-Dose Methotrexate for Reduction of Global Initiative for Asthma Step 5 Treatment in Severe Refractory Asthma: Study Protocol for a Randomized Controlled Trial.” Trials 15 (1): 295–310. doi:10.1186/1745-6215-15-492.